Voriconazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 200 mg
Reference Brands: Vfend(US & EU)
Category:
Anti-fungal
Voriconazole tablets inhibit fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane formation. They provide broad-spectrum antifungal activity, including against Aspergillus and Candida. Benefits include oral administration, excellent tissue penetration, rapid action, and high efficacy in treating invasive fungal infections, improving patient outcomes.
Voriconazole Tablets is available in Tablets
and strengths such as 50 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Voriconazole Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Voriconazole Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Voriconazole tablets are approved in the EU and US for treating invasive fungal infections. In the EU, Pfizer’s Vfend is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial authorization and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz, your trusted partner in regulatory solutions. We help ensure smooth market access and adherence to European and American standards for voriconazole tablets, supporting your product’s global success.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing